AxoGen Announces Closing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Apple sues OpenAI, two former employees for trade secrets theft
AxoGen, Inc. (AXGN) PT Raised to $27 at Wedbush Following Investor Day
November 21, 2017 9:44 AM ESTWedbush raised its price target on AxoGen, Inc. (NASDAQ: AXGN) to $27.00 (from $22.00) while maintaining a Outperform rating following the company's investor day. Analyst Tao Levy came away with greater confidence and clarity around the company's new market opportunities within peripheral nerve repair.
Management... More
AxoGen, Inc. (AXGN) PT Raised to $27 at JMP Securities Following Analyst Day
November 21, 2017 8:04 AM ESTJMP Securities raised its price target on AxoGen, Inc. (NASDAQ: AXGN) to $27.00 (from $25.00) while maintaining a Market Outperform rating following the company's analyst day. JMP's new $27 target is based on 8-9x EV/Sales on 2019 revenue estimates of $105 mln.
The company continued... More
